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ABSTRACT
Cancer-secreted exosomes influence tumor microenvironment and support cancer growth and metastasis.
MiR-210 is frequently up-regulated in colorectal cancer tissues and correlates with metastatic disease. We
investigated whether exosomes are actively released by HCT-8 colon cancer cells, the role of exosomal
miR-210 in the cross-talk between primary cancer cells and neighboring metastatic cells and its
contribution in regulating epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition
(MET).
After 7 d of culture, a subpopulation of viable HCT-8 cells detached the monolayer and started to grow in
suspension, suggesting anoikis resistance and a metastatic potential. The expression of key proteins of
EMT revealed that these cells were E-cadherin negative and vimentin positive further confirming their
metastatic phenotype and the acquisition of anoikis resistance. Metastatic cells, in the presence of
adherently growing HCT-8, continued to grow in suspension whereas only if seeded in cell-free wells, were
able to adhere again and to form E-cadherin positive and vimentin negative new colonies, suggesting the
occurrence of MET.
The chemosensitivity to 5 fluorouracil and to FOLFOX-like treatment of metastatic cells was significantly
diminished compared to adherent HCT-8 cells. Of note, adherent new colonies undergoing MET, were
insensitive to both chemotherapeutic strategies. Electron microscopy analysis demonstrated that
adherently growing HCT-8, actually secreted exosomes and that exosomes in turn were taken up by
metastatic cells. When exosomes secreted by adherently growing HCT-8 were administered to metastatic
cells, MET was significantly inhibited. miR-210 was significantly upregulated in exosomes compared to its
intracellular levels in adherently growing HCT-8 cells and correlated to anoikis resistance and EMT markers.
Exosomes containing miR-210 might be considered as EMT promoting signals that preserve the local







A continuous cross-talk between cancer cells and local/distant
environments is required for effective tumor growth and sys-
temic dissemination.1 Intercellular communication can occur
through cell-cell direct contact mediated by gap junctions as
well as by extracellular vesicles.2 Exosomes, are 30–100 nm
phospholipid bilayer-enclosed vesicles surrounding a small
cytosol which are increasingly recognized as key autocrine and
paracrine mediators of cell-cell communication through the
transport of bioactive molecules such as mRNAs, proteins and
microRNAs (miRNAs).3 Exosomes from breast cancer cells
transfer miRNAs to normal cells, stimulate them to become
cancerous4 and promote cell invasion.5 It has been suggested
that the formation of the “pre-metastatic niches” depends on
tumor-derived exosomes but the contribution of miRNAs has
not been addressed.6 The elegant study of Lieberman and her
group also clearly demonstrated that the metastatic capability
can be transferred between metastatic and non-metastatic can-
cer cells via exosomes containing miR-200.7
Epithelial–mesenchymal transition (EMT), characterized by
the loss of epithelial traits and the acquisition of a mesenchymal
phenotype is involved in cancer progression and metastasis.8 If
EMT is critical to the initial transformation from benign to
invasive carcinoma, its reverse process, the mesenchymal-to-
epithelial transition (MET), is central for the latter stages of the
metastatic process.8 Several miRNAs have been reported to
control multiple aspects of EMT and MET and to support
tumor progression and metastasis.9,10
MiR-210 is frequently up-regulated in colorectal cancer tis-
sues and its expression correlates with aggressive disease and
metastasis.11 A recent study demonstrated that the circulating
levels of miR-210 are significantly elevated in colorectal cancer
patients and correlate to the occurrence of distant metastasis.12
Although these studies suggest that mir-210 is associated to
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colon cancer metastasis they did not show whether colon can-
cer cells indeed secrete exosomes containing miR-210 and their
relevance in the paracrine communication with nearby dissem-
inated cancer cells.
On these basis, by using an in vitro model of spontaneous
metastasis of colon cancer cells, we aimed at investigating
whether exosomes are actively released by cancer cells to mod-
ify the local tumor environment, the role of exosomal miR-210
in the cross-talk between primary cancer cells and metastasis
and its contribution in regulating EMT and MET.
Materials and methods
Cell line and metastatic cells
HCT-8 cells (gift from Dr. Coronnello, University of Florence)
were maintained in DMEM (Invitrogen, Life technologies,
Carlsbad, USA) supplemented with 10% fetal bovine serum
(Invitrogen), 100 U/mL penicillin-streptomycin, 1% l-gluta-
mine (200 mmol/L), 4.5 g/L glucose and grown in 5% CO2.
After 48 hours from seeding, several cells able to survive in sus-
pension, spontaneously appeared in the culture medium. These
cells were interpreted as potentially metastatic and their
number was assessed at different time points from seeding
(48 h, 72 h, 96 h; 7 d, 10 d, 15 d). Cell viability was measured
by trypan blue (Invitrogen).
Immunocytochemistry
To characterize the phenotype of cells growing in suspension,
the expression of E-cadherin and vimentin was assessed by
immunocytochemistry. Cells were prepared as follows: a) HCT-
8 cells seeded on histological slides, b) potentially metastatic cells
placed on histological slides by 500xg centrifugation for
5 minutes, c) potentially metastatic cells seeded in HCT-8 free-
wells and collected as soon as they formed adherent visible colo-
nies. Samples were fixed in 4% formaldehyde pH 7.4 for 10 min
and pre-incubated in 0.5% triton and 1.5% bovine serum albu-
min (BSA) (Sigma Aldrich, Milan, Italy) for 15 min at room
temperature. Immunostaining was performed by incubation for
24 h at 4Cwithmouse monoclonal anti E-cadherin at final dilu-
tion of 1:50 (Millipore, Billerica, MA, USA) or goat-polyclonal
anti-Vimentin at final dilution 1:40 (Sigma Aldrich) followed by
Alexa Fluor 488 Goat anti mouse (1:333) or Alexa Fluor 568
Donkey anti Goat (1:333) (Invitrogen).
Image acquisition and analysis
Microscopic analysis was performed with a fluorescence micro-
scope (Labophot-2, Nikon, Tokyo, Japan) connected to a CCD
camera. Ten photomicrographs (»100 cells/microscopic field)
were randomly taken for each sample and fluorescence was
measured using ImageJ 1.33 image analysis software (http://
rsb.info.nih.gov/ij). Results were expressed in arbitrary units.
Exosomes isolation
Exosomes were obtained from HCT-8 culture media at day 7
post seeding by using the Exosome Precipitation Solution
(Macherey-Nagel, D€uren, Germany) following the manufac-
turer’s instructions.
Transmission electron microscopy
HCT-8 (106 cells) were fixed in 4% glutaraldehyde (Electron
Microscopy Sciences, Hatfield, PA, USA) for 8 h at 4C. Cells
were then embedded in epoxy resin and routinely processed. In
order to evaluate the interaction between metastatic cells and
exosomes, 105 metastatic cells were incubated for 30 min at
37C with 10% exosomes suspension obtained as described
above. At the end of the incubation, cells were fixed and
embedded for transmission electron microscopy. Samples were
cut in sections about 70 nm thick and examined with a Jeol
1010 transmission electron microscope (Jeol, Tokyo, Japan) at
80 kV.
RNA extraction from exosomes and from adherent HCT-8
cells
Total RNA from exosomes was extracted using the NucleoSpin
miRNAs Plasma kit (Macherey-Nagel, D€uren, Germany). Total
RNA from adherent HCT-8 cells was isolated using the miR-
Neasy Mini Kit (Qiagen Duesseldorf, Germany). Reverse tran-
scription of RNA was performed using the miScript Reverse
Transcription Kit according to manufacturer’s instructions
(Qiagen). In the case of exosomal miRNA, cDNAs were pream-
plified with MiScript Pre-AMP (Qiagen).
mir-210 expression in exosomes and in adherent HCT-8
cells
Quantitative real-time RT-PCR was performed in 7900HT Fast
Real-Time PCR System (Applied Biosystems, California, USA)
using miScript SYBR Green PCR Kit and miScript Primer
Assay according to manufacturer’s instructions (Qiagen). Cel-
miR-39 was used for the normalization of both exosomal and
intracellular miRNAs levels according to Turchinovich et al.13
After amplification, melting curve analysis was performed to
ensure the specificity of the products. The expression levels of
miR-210 were calculated as 2¡^DDCT.
Colonies formation
Metastatic cells were isolated from HCT-8 culture media by
500xg centrifugation for 5 min. 4 £ 103 cells were seeded in 24
well plates and maintained for 72 h in DMEM or in DMEM
containing 5% or 10% of exosomes obtained as described
above. Adherent new colonies were then counted.
Chemotherapy sensitivity
The chemosensitivity of the 3 cell clones was assessed. Adher-
ent HCT-8 cells, metastatic cells and adherent new colonies
were treated for 72 h with 5-fluorouracil (5FU) 10¡6 M 14 and
with a FOLFOX-like treatment (5FU 10¡6 M C Oxaliplatin
2 £ 10¡7 M) (Sigma Aldrich, Milan, Italy). Cells viability was
assessed by MTS assay (Promega Corporation, WI). The optical
density of the chromogenic product was measured at 490 nm.
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Statistical analysis
Data were expressed as means § SEM of 3 independent experi-
ments. Statistical analysis was performed by one-way analysis
of variance, followed by the Student–Newman–Keuls multiple
comparison post hoc test or by Mann-Whitney test. Calcula-
tions were done using a GraphPad Prism 4.0 (GraphPad
software, San Diego, CA).
Results
A subpopulation of viable HCT-8 cells spontaneously goes
in suspension
After 48h post-seeding, a number of HCT-8 cells spontaneously
began to disassociate, migrated away from the cell monolayer
and remained fully viable in the culture media. The number of
these cells significantly increased from the seventh to the
fifteenth day post-seeding (Fig. 1).
The key epithelial-mesenchymal transition (EMT) markers
Vimentin and E-cadherin, are differentially expressed in
adherent HCT-8 and in those in suspension
At day 7 from seeding, immunofluorescent staining for E-cad-
herin and Vimentin considerably differed when we compared
to adherently growing HCT-8 cells with those in suspension.
Suspended viable HCT-8 cells were E-cadherin negative (Fig. 2,
panel C) and vimentin positive (Fig. 2, panel D) whereas the
adherent originating HCT-8 cells, were E-cadherin positive
(Fig. 2, Panel A) and vimentin negative (Fig. 2, panel B). Densi-
tometric analysis further supported these results; in fact, sus-
pended HCT-8 cells (namely metastatic cells) displayed
significantly lower levels of E-cadherin and significantly higher
levels of vimentin compared to the adherent originating HCT-
8 cells (p < 0.01) (Fig. 2, panel G and panel H). Interestingly,
these metastatic cells, only if seeded in cell-free wells, formed
new, adherent, E-cadherin positive and vimentin negative colo-
nies (Fig. 2, panel E and panel F), suggesting the occurrence of
MET. Densitometric analysis confirmed that the adherent new
colonies expressed significantly lower levels of vimentin and
higher E-cadherin levels compared to metastatic cells
(p < 0.01) (Fig. 2, panel G and panel H).
HCT-8 secrete exosomes which in turn interact with
neighboring metastatic cells
In the cytoplasm of HCT-8 cells, transmission electron micros-
copy (TEM) highlighted several intracellular multi-vesicle bod-
ies (MVBs) carrying bi-lipidic membrane-bound exosome-like
vesicles (Fig. 3, panel A). Metastatic cells did not show any
MVBs in their cytoplasm but several round bodies compatible
with exosome-like vesicles, were identified closely to their
membrane. In some cases these round bodies appeared fused
with the metastatic cells membrane (Fig. 3, panel B and C).
The adhesion dynamic of metastatic cells is influenced by
miR-210
To test directly if exosomes are indeed able to influence the
adhesion of metastatic cells, 5 or 10 % of exosomes from HCT-
8 was administered to metastatic cells. In the presence of exo-
somes, the number of adherent, new colonies expressing E-cad-
herin, was significantly decreased compared to control culture
conditions, further supporting the role of exosomes also in the
MET process (Fig. 3, panel D). Interestingly, we found that
miR-210 was significantly upregulated in exosomes compared
to adherently growing HCT-8 from which they arise (Fig. 3,
panel E) and that these exosomes in turn were taken up by
nearby disseminated cells (Fig. 3, panel B and C).
The three cell clones show different sensitivity to standard
chemotherapy
As expected, adherent HCT-8 cells were sensitive to standard
chemotherapy with a percentage of cell death of 30 % upon
5FU and of 50 % upon FOLFOX- like treatment. This sensitiv-
ity was significantly diminished in metastatic cells compared to
adherent HCT-8 cells. Of note, adherent new colonies undergo-
ing MET, were completely insensitive to both 5FU and FOL-
FOX- like treatment (Fig. 4).
Discussion
The metastatic process remains one of the most unknown
aspects of tumor biology and accounts for 90% of cancer mor-
tality. The identification of the key molecular mechanisms reg-
ulating metastasis is therefore of paramount importance for the
discovery of novel therapeutic approaches.15
Our results demonstrate that a sub-population of HCT-8
cells spontaneously disassociated, migrated away from the cell
monolayer and remained viable in suspension. It might be
argued that this phenomenon could be due to a physiological
transition between adherent and suspended cells: if so, the
number of cells in suspension would likely remains constant
over time. Our findings instead demonstrated that this is not
the case since the number of fully viable cells in suspension
increased over time in culture medium, suggesting that HCT-8
actually and progressively underwent a phenotypic transition
from an adhesive epithelial type to a subpopulation of cells
with a metastatic-like phenotype. Interestingly, a similar behav-
ior was reported by Tang et al. (2014) who discovered that
HCT-8 cells can exhibit a dissociative, metastasis-like
Figure 1. At different time points post seeding, a subpopulation of viable HCT-8
cells spontaneously goes in suspension. Data are expressed as means § SEM of 3
independent experiments. p < 0.001 vs 48h.
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phenotype in vitro.16 Moreover, as barrier to metastases, cells
normally undergo an apoptotic cell death called “anoikis” after
they lose contact with their neighboring cells.17 In our model, a
subpopulation of HCT-8 cells likely acquired resistance to
anoikis and were thus able to survive after detachment from
the “primary colonies.”
Increased invasive and metastatic potential has been associ-
ated to the epithelial-mesenchymal transition (EMT). EMT is
Figure 2. Immunocytochemical evaluation of the expression of E-cadherin (panel A) and vimentin (panel B) in adherently growing HCT-8. Expression of E-cadherin (panel C) and
vimentin (panel D) in metastatic cells growing in suspension. Expression of E-cadherin (panel E) and vimentin (panel F) in adherent new colonies obtained by seeding metastatic
cells in cell-free wells (20x magnification; Barr 100 mm objective). Panel G: Densitometric analysis of E-cadherin in adherently growing HCT-8, in metastatic cells growing in sus-
pension and in adherent new colonies obtained by seeding metastatic cells in cell-free wells. Panel H: Densitometric analysis of vimentin in adherently growing HCT-8, in meta-
static cells growing in suspension and in adherent new colonies obtained by seeding metastatic cells in cell-free wells. p< 0.01 vs metastatic cells growing in suspension.
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not only a key event for epithelial cells to acquire a motile and
invasive phenotype, but also an essential process for anoikis
resistance.8,18 Among the hallmarks of EMT in vitro and
in vivo, the up-regulation of mesenchymal markers (N-cad-
herin and vimentin) and the down-regulation of epithelial
markers (E-cadherin and cytokeratins) were frequently
reported.19 In our results, the conversion from an epithelial
into a mesenchymal phenotype, suggests that HCT-8 cells
spontaneously undergo through an EMT process and acquire a
metastatic potential. The loss of E-cadherin expression in fact,
allows tumor cells to dissociate from the primary tumor, to
overcome anoikis and disseminate.20 Successful metastatic col-
onization seems to require also the reverse process known as
mesenchymal-epithelial transition (MET). Infact, to invade
other sites, cancer cells, that have undergone EMT, must re-
acquire epithelial characteristics to anchor in the surrounding
tissue.21 Interestingly, our metastatic cells, only if seeded in
cell-free wells, formed new, adherent, E-cadherin positive and
vimentin negative colonies suggesting that the occurrence of
MET might be regulated by a paracrine signal sent by adherent
HCT-8 cells to the metastatic ones.
In recent years, exosomes have received increasing attention
for their role in regulating and transferring molecules responsi-
ble for tumor progression and metastasis.22 We therefore inves-
tigated if exosomes might represent a mechanism trough which
adherent HCT-8 cells communicate with neighboring dissemi-
nated cancer cells and modify their adhesion. The ability of
HCT-8 cells to actually secrete exosomes was confirmed by
transmission electron microscopy: cytoplasmic structures iden-
tical to those described in exosomes secreting cells were infact
identified.22 Electron microscopy also demonstrated the pres-
ence of extracellular microvesicles nearby metastatic cells incu-
bated with exosomes secrete by adherent HCT-8 cells. This
finding may be indicative of both exosome release and uptake
but the lack of intracellular multi-vesicle bodies enclosing exo-
somes in metastatic cells, strongly suggests the interaction with
exogenous exosomes secreted from adherently growing HCT-8.
This is also supported by the discovery that this interaction has
a functional consequence on metastatic cells: infact, when exo-
somes isolated from primary HCT-8 culture media were
Figure 3. Morphological analysis of exosomes. (Panel A) Transmission electron microscopy of HCT-8 cells showing micro vesicles enclosing bilipidic layer-bound exo-
somes (black arrow) (20,000X, scale bar 1 mm). (Panel B) Metastatic cell cultured with 10% exosome suspension (10,000X, scale bar 2 mm). (Panel C) Higher magnifica-
tion of panel B. Two microvescicles are located closed to cell membrane (black arrows), one appears fused with cell membrane (arrow head); (50,000X, scale bar
500 nm). (Panel D) Number of adherent new colonies formed by metastatic cells in the presence and absence of exosomes p < 0.001 vs DMEM. (Panel E) miR-210
expression in adherently growing HCT-8 and in exosomes, analyzed using real-time RT-PCR. p < 0.05.
Figure 4. Chemotherapy sensitivity in the 3 different cell clones. Data are
expressed as means § SEM of 3 independent experiments. p < 0.001 vs adher-
ent HCT-8 cells.
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administered to metastatic cells, the number of colonies formed
by metastatic cells in cell-free wells, was significantly reduced.
In the last few years, a number of studies have demonstrated
that exosomes contribute to EMT, invasion and metastasis.20
The novelty of our findings is the documentation that exo-
somes modify the adhesion dynamic of neighboring metastatic
cells and are involved in the MET process. Moreover, E-cad-
herin re-expression is usually induced by factors secreted by a
secondary organ microenvironment.21 Here we demonstrated
that the adhesion of metastatic cells and the re-expression of E-
cadherin is also driven in a cell-free well where they were no
longer in the presence of the originating HCT-8 cells. This find-
ing suggests that in its own local microenvironment, the pri-
mary tumor itself, by secreting exosomes, hinders E-cadherin
re-expression in nearby metastatic cells possibly to preserve its
local permissive milieu.
To investigate the mechanism involved, we measured the
expression of mir-210, known to be raised in colorectal cancer
patients and to correlate to the occurrence of distant metasta-
sis.12 miR-210 was significantly up-regulated in exosomes com-
pared to its intracellular levels in adherently growing HCT-8
cells and correlated to anoikis resistance and EMT markers.
Mudduluru and coworkers, recently performed a systematic
analysis of the metastasis-associated miRNome.22 These
authors demonstrated that colorectal cancer cell lines trans-
fected with miR-210 displayed a significant decrease in E-cad-
herin expression and a parallel increase of N-cadherin
expression, an increased migration and invasive capacity and
an enhanced ability to metastasize in vivo. The expression of
miR-210 was found to correlate with EMT markers also in
human gastric and ovarian cancer cells.23-24
To better understand the characteristics of metastatic cells
and of the new adherent colonies undergoing MET, a chemo-
therapy sensitivity assay was performed. The three different cell
populations were exposed to 5FU or to a combination of 5FU
plus oxaliplatin (5:1) to mimic FOLFOX treatment, commonly
used strategies to treat colorectal cancer.25 We demonstrated
that metastatic cells undergoing EMT were much more resis-
tant to standard chemotherapy compared to the adherent cells.
Studies using colorectal cell lines have shown that EMT
inducers also increased resistance to chemotherapy.26 Con-
versely, oxaliplatin-resistant colorectal cell lines showed pheno-
typic and gene expression changes consistent with EMT.27
Recently, lung adenocarcinoma cell lines exhibiting TGF-
b/FGF-2-induced EMT, were also chemoresistant to gefitinib
and chemically induced EMT reversion only partly restored
chemosensitivity.28 Studies investigating the potential survival
advantage of cancer cells undergoing MET toward conven-
tional chemotherapy are scarce and it is unclear whether EMT-
driven therapy resistance is retained after cells undergo MET.
We are among the first to demonstrate that cells undergoing
MET are insensitive to conventional chemotherapy highlight-
ing the importance to characterize this phenomenon to com-
prehend the EMT/MET axis in cancer and resistance to
therapy. Infact, whereas the inhibition of EMT may be effective
in preventing the invasive dissemination of organ-confined
cancers, in the latter stages, it could also accelerate MET-
dependent colonization of new sites of dissemination and
increase chemoresistance.
Cancer cells manipulate their microenvironment to optimize
conditions for growth and metastasis in multiple ways. Our
hypothesis is that in our model, through the delivery of mir-
210 to nearby metastatic cells, primary tumor gains a double
evolutionary advantage: on one hand, it preserves its local can-
cer-growth permissive milieu in terms of space and nutrients
and on the other hand, it also redirects metastatic homing to
distant sites. Infact we demonstrated that disseminated cancer
cells which leave the “primary site” revert to the epithelial state
in the absence of exosomes containing mir-210. Thus, in the
absence of the EMT-inducing signals received from the “pri-
mary site,” metastatic cancer cells may fall back into an epithe-
lial state when entering into new, free sites of dissemination.
This evolutionary vision of cancer agrees with the “Seed and
soil” theory formulated by Paget29 in which metastatic cells are
Figure 5. Schematic diagram depicting the major findings of this work.
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“seeds” and a particular microenvironment or niche, serves as
the “soil.” In this vision, exosomes represent an instrument of
communication which allows the primary tumor not only to
create favorable conditions of “soil” in remote niches but also
to prevent metastatic cells adhesion in its own “soil” avoiding
unfavorable local conditions. In the last few years, this ecologi-
cal vision of cancer has been suggested to be useful to under-
stand the biology of metastasis and stimulate the discovery of
new therapeutic strategies.30
As summarized in Fig. 5, we have demonstrated that exo-
somes containing miR-210 mediate the cross-talk between pri-
mary cancer cells and nearby disseminated cells, and redirect
metastatic cells homing to free sites of dissemination, leading
to the discovery of a new molecular mechanisms involved in
the primary cancer niche preservation.
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